1. Signalling Programme,
2. Lymphocyte Signalling Programme,
3. Bioinformatics Group, and
4. Flow Cytometry Facility, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom;
5. Center of Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and
6. Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King’s College London, London, United Kingdom